Results of a modified Delphi consensus on the optimal testing pathway for oesophago-gastric cancer care in the UK
The recommendations support the use of a reflex testing approach for human epidermal growth factor receptor 2, programmed death ligand 1 and microsatellite instability high/mismatch repair deficiency in patients diagnosed with OG cancer who are suitable for treatment with targeted therapy.
Authors
- Naureen Starling (ORCID: https://orcid.org/0000-0002-1496-6792)
- Manuel Rodriguez‐Justo (ORCID: https://orcid.org/0000-0001-5007-1761)
- Philippe Tanière (ORCID: https://orcid.org/0000-0002-4638-4551)
- Thomas Bird
- Wasat Mansoor
- Martin Eatock
Institutions
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- Royal Marsden Hospital (GB)
- The Northern Ireland Cancer Centre (GB)
- The Christie Hospital (GB)
- University College London (GB)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-094343
- Primary Topic
- Delphi Technique in Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Merck